文献速递腹部MR

细胞外对比剂与肝胆特异性对比剂MRI对局部治疗后残留肝细胞癌诊断准确性的比较

Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本研究以肝移植标本为参考标准,比较细胞外钆对比剂增强MRI(Gd-MRI)与钆塞酸增强MRI(EOB-MRI)评估肝细胞癌局部治疗后残留病灶的诊断准确性,纳入49例肝硬化肝细胞癌局部治疗后90天内行肝MRI检查者(Gd-MRI组26例、EOB-MRI组23例)。Gd-MRI与组织学一致性更高(ICC 0.98 vs 0.80),检出存活肝细胞癌的敏感度更高(76% vs 58%),特异度相似(84% vs 85%),ROC曲线下面积分别为0.80与0.72。结论认为Gd-MRI在评估局部治疗后存活肝细胞癌方面可能比EOB-MRI更准确、更精确。

要点

  • 以移植标本为参考,Gd-MRI检出残留存活肝细胞癌敏感度76%,EOB-MRI为58%。
  • Gd-MRI与组织学一致性ICC 0.98,高于EOB-MRI的0.80。
  • 两者特异度相似(84% vs 85%),但Gd-MRI的敏感度更高。

核心结论

  • Gd-MRI在评估局部治疗后存活肝细胞癌方面可能比EOB-MRI更准确、更精确。

研究设计与样本

  • 以移植标本为参考标准的诊断准确性比较研究,纳入49例肝硬化肝细胞癌局部治疗后90天内行肝MRI者,Gd-MRI组26例、EOB-MRI组23例,由4名放射科医师盲法阅片。

关键影像表现/征象

  • 评估残留存活肝细胞癌大小与组织学的一致性:Gd-MRI的ICC为0.98(95%CI 0.95-0.99),EOB-MRI为0.80(95%CI 0.63-0.90)。
  • 评估残留存活肝细胞癌大小的阅片者间一致性:Gd-MRI的ICC为0.96(95%CI 0.92-0.98),EOB-MRI为0.85(95%CI 0.72-0.92)。

诊断标准与关键数值

  • 检出存活肝细胞癌的敏感度:Gd-MRI为76%(13/17,95%CI 50-93%),EOB-MRI为58%(7/12,95%CI 28-85%)。
  • 检出存活肝细胞癌的特异度:Gd-MRI为84%(16/19,95%CI 60-97%),EOB-MRI为85%(23/27,95%CI 66-96%)。
  • 检出残留存活肿瘤的ROC曲线下面积:Gd-MRI为0.80(95%CI 0.64-0.92),EOB-MRI为0.72(95%CI 0.55-0.85)。

临床应用与阅片要点

  • 作者认为Gd-MRI在评估局部治疗后存活肝细胞癌方面可能比EOB-MRI更准确、更精确。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the diagnostic accuracy of extracellular gadolinium-based contrast-enhanced MRI (Gd-MRI) and gadoxetic acid-enhanced MRI (EOB-MRI) for the assessment of hepatocellular carcinoma (HCC) response to locoregional therapy (LRT) using explant correlation as the reference standard.

METHODS: Forty-nine subjects with cirrhosis and HCC treated with LRT who underwent liver MRI using either Gd-MRI (n = 26) or EOB-MRI (n = 23) within 90 days of liver transplantation were included. Four radiologists reviewed the MR images blinded to histology to determine the size and percentage of viable residual HCC using a per-lesion explant reference standard. Sensitivities, specificities, accuracies, and agreement with histology for the detection residual HCC were calculated.

RESULTS: Gd-MRI had greater agreement with histology (ICC: 0.98 [0.95-0.99] vs. 0.80 [0.63-0.90]) and greater sensitivity for viable HCC (76% [13/17 50-93%] vs. 58% [7/12; 28-85%]) than EOB-MRI; specificities were similar (84% [16/19; 60-97%] vs. 85% [23/27; 66-96%]). Areas under ROC curves for detecting residual viable tumor were 0.80 (0.64-0.92) for Gd-MRI and 0.72 (0.55-0.85) for EOB-MRI. Gd-MRI had greater inter-rater agreement than EOB-MRI for determining the size of residual viable HCC (ICC: 0.96 [0.92-0.98] vs. 0.85 [0.72-0.92]).

CONCLUSION: Gd-MRI may be more accurate and precise than EOB-MRI for the assessment of viable HCC following LRT.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Rimola J, Davenport MS, Liu PS, et al. Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment. Abdom Radiol (NY). 2019. PMID: 30218239. doi:10.1007/s00261-018-1775-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。